Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date- |
多种油脂肪乳(C6-24)/氨基酸(16)/葡萄糖(42%)和电解质注射液与 “全合一”肠外营养混合液相比的有效性和安全性研究
[Translation] Efficacy and safety study of multiple oil fat emulsion (C6-24)/amino acid (16)/glucose (42%) and electrolyte injection compared with "all-in-one" parenteral nutrition mixture
主要目的:为证实SmofKabiven输注乳剂(研究药物)对血清前白蛋白水平的影响非劣效于医院配置的“全合一”肠外营养混合液(对照药物)。次要目的:为评估SmofKabiven输注乳剂与院内配置的“全合一”肠外营养混合液相比的术后新发院内感染发生率,以及前白蛋白(第4天)、CRP、游离脂肪酸、TXB3/TXB2、IL-1、IL-2、 IL-6、CD4/CD8、牛磺酸水平和安全性
[Translation] Main purpose: To confirm that the effect of SmofKabiven infusion emulsion (study drug) on serum prealbumin levels is non-inferior to hospital-prepared "all-in-one" parenteral nutrition mixture (control drug). Secondary objectives: To evaluate the incidence of postoperative new nosocomial infections, as well as prealbumin (day 4), CRP, free fatty acids, infusion of SmofKabiven emulsion compared with in-hospital "all-in-one" parenteral nutrition mixtures , TXB3/TXB2, IL-1, IL-2, IL-6, CD4/CD8, taurine levels and safety
多种油脂肪乳(C6-24)/氨基酸(16)/葡萄糖(13%)电解质注射液与“全合一”肠外营养混合液相比的有效性和安全性研究
[Translation] Efficacy and safety study of multiple oil fat emulsion (C6-24)/amino acid (16)/glucose (13%) electrolyte injection compared with "all-in-one" parenteral nutrition mixture
主要目的: 通过观察药物对血清前白蛋白水平的影响,评估并比较SmofKabiven Peripheral与医院配置的“全合一”肠外营养混合液的有效性。 次要目的: 对SmofKabiven Peripheral与医院配置的“全合一”肠外营养混合液相比的CRP、游离脂肪酸、免疫学参数、牛磺酸、安全性和配置时间进行评估。
[Translation] Main purpose: To evaluate and compare the effectiveness of SmofKabiven Peripheral and hospital-prepared "all-in-one" parenteral nutrition mixture by observing the effect of drugs on serum prealbumin levels. Secondary Objectives: To evaluate CRP, free fatty acids, immunological parameters, taurine, safety, and time to preparation of SmofKabiven Peripheral compared to a hospital-prepared "all-in-one" parenteral nutrition mix.
100 Clinical Results associated with Fresenius Kabi AB
0 Patents (Medical) associated with Fresenius Kabi AB
100 Deals associated with Fresenius Kabi AB
100 Translational Medicine associated with Fresenius Kabi AB